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ABSTRACT   
During infection, the fungal pathogen Aspergillus 
fumigatus forms biofilms that enhance its resistance 
to antimicrobials and host defenses. An integral 
component of the biofilm matrix is 
galactosaminogalactan (GAG), a cationic polymer 
of α-1,4-linked galactose and partially deacetylated 
N-acetylgalactosamine (GalNAc). Recent studies 
have shown that recombinant hydrolase domains 
from Sph3, an A. fumigatus glycoside hydrolase 
involved in GAG synthesis, and PelA, a multi-
functional protein from Pseudomonas aeruginosa 
involved in Pel polysaccharide biosynthesis, can 
degrade GAG, disrupt A. fumigatus biofilms, and 
attenuate fungal virulence in a mouse model of 
invasive aspergillosis. The molecular mechanisms 
by which these enzymes disrupt biofilms have not 
been defined. We hypothesized that the hydrolase 
domains of Sph3 and PelA (Sph3h and PelAh, 
respectively) share structural and functional 
similarities given their ability to degrade GAG and 
disrupt A. fumigatus biofilms. MALDI-TOF 
enzymatic fingerprinting and NMR experiments 
revealed that both proteins are retaining endo-α-
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1,4-N-acetylgalactosaminidases with a minimal 
substrate size of seven residues. The crystal 
structure of PelAh was solved to 1.54 Å and 
structure alignment to Sph3h revealed that the 
enzymes share similar catalytic site residues.  
However, differences in the substrate binding clefts 
result in distinct enzyme-substrate interactions. 
PelAh hydrolyzed partially deacetylated substrates 
better than Sph3h, a finding that agrees well with 
PelAh’s highly electronegative binding cleft versus 
the neutral surface present in Sph3h. Our insight 
into PelAh’s structure and function necessitate the 
creation of a new glycoside hydrolase family, 
GH166, whose structural and mechanistic features, 
along with those of GH135 (Sph3), are reported 
here. 
INTRODUCTION 
Aspergillus fumigatus is a ubiquitous filamentous 
fungus that causes invasive pulmonary infections in 
patients who are immunosuppressed due to 
cytotoxic chemotherapy, organ and stem cell 
transplantation, or biological therapies such as 
tumor necrosis factor inhibitors (1-3). During 
pulmonary infection, filamentous hyphae of A. 
fumigatus grow within biofilms: multicellular 
communities of organisms embedded in a self-
produced extracellular matrix (4). This biofilm 
extracellular matrix plays several roles in the 
pathogenesis of invasive aspergillosis including 
mediating the adherence of hyphae to host tissues 
and enhancing resistance to antifungal drugs and 
host immune defenses (5-8). 
Solid-state NMR spectroscopy analyses have 
revealed that polysaccharides are the most abundant 
component of the A. fumigatus extracellular matrix 
(9). Immunohistochemical and electron microscopy 
studies of Aspergillus biofilms have identified α-
1,3-glucan, galactomannan and 
galactosaminogalactan (GAG) as key 
polysaccharide components of the matrix (10). 
GAG is a linear cationic polymer of α-1,4-D-
galactose and partially deacetylated α-1,4-N-acetyl-
D-galactosamine (GalNAc) that is produced by 
activity of the products of a five-gene cluster 
located on the chromosome 3 (11). GAG synthesis 
is thought to be initiated by the synthesis of UDP-
GalNAc and UDP-Gal by the glucose-4-epimerase 
Uge3 (12). These sugars are then linked and 
exported through the action of the predicted 
glycosyltransferase Gtb3, and the resulting polymer 
is partially deacetylated in the extracellular space 
by secreted Agd3 (13). Cleavage of the emerging 
polymer is thought to be mediated by two glycoside 
hydrolases encoded within this gene cluster, Sph3 
and Ega3 (11). GAG, plays a central role in biofilm 
formation and virulence (14). GAG-deficient 
strains are markedly impaired in their ability to 
form biofilms and adhere to pulmonary epithelial 
cells in vitro (15). Hyphal-associated GAG 
enhances resistance to neutrophil extracellular traps 
(16) and conceals pathogen-associated molecular 
patterns such as ß-glucan from immune detection 
(17). Secreted GAG also promotes infection by 
inducing neutrophil apoptosis and the production of 
the anti-inflammatory cytokine IL-1 receptor 
antagonist (18). Consistent with these observations, 
GAG-deficient strains of A. fumigatus exhibit 
attenuated virulence in mouse models of invasive 
aspergillosis (17). 
The importance of GAG in biofilm formation and 
virulence suggest that this exopolysaccharide is a 
promising therapeutic target. We recently reported 
that the recombinant glycoside hydrolase domains 
from two microbial proteins, A. fumigatus Sph3 and 
Pseudomonas aeruginosa PelA, degrade GAG and 
disrupt A. fumigatus biofilms (19). PelA is a 
multidomain protein with both deacetylase and 
glycoside hydrolase activity that is required for 
production of the P. aeruginosa Pel polysaccharide 
(20-22). In addition to its degrading A. fumigatus 
biofilms, the recombinant hydrolase domain of 
PelA (PelAh) also disrupts Pel-dependent biofilms 
of P. aeruginosa (21). While, the structure and 
anomeric configuration of the Pel polysaccharide 
remains to be determined, it has been found to 
contain partially deacetylated 1,4-linked GalNAc 
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(20,23). The presence of GalNAc-rich regions in 
both the GAG and Pel polysaccharides suggests 
that PelAh may also be specific for GalNAc.    
Structural and functional characterization of 
glycoside hydrolase domain of Sph3 (Sph3h) 
revealed that this enzyme is essential for GAG 
biosynthesis and belongs to the glycoside hydrolase 
(GH) family 135 (24). Sph3h has an ()8 fold with 
a shallow conserved active site groove. Co-
crystallization of Sph3h with GalNAc and 
mutagenesis of residues within the active site 
groove suggest that this enzyme hydrolyses GAG 
within GalNAc-rich regions of the polymer (24).  
Less is known about structure and function of the 
glycoside hydrolase domain of PelA, which is 
predicted by Phyre2 to contain a ()-barrel fold 
(20) and by the conserved domain database to 
belong to the GH114 superfamily 
(https://www.ncbi.nlm.nih.gov/Structure/cdd/ 
wrpsb.cgi). However, a BLAST search against all 
CAZy, GH114 members, and a search of the 
sequence against all Hidden Markov Models of 
CAZy families, failed to find any significant 
sequence identity with classified glycoside 
hydrolases, suggesting that PelAh belongs to a new 
CAZy family.  
Herein, we characterize the molecular mechanisms 
underlying the cross-kingdom GAG activity of the 
glycoside hydrolases, Sph3h and PelAh. Mass 
spectrometry enzymatic fingerprinting and NMR 
studies revealed that both enzymes share retaining 
endo-α-1,4-N-acetylgalactosaminidase activity and 
require a minimal substrate length of seven GalNAc 
residues. The substrate interacts with the binding 
cleft differently in the two enzymes leading Sph3h 
to cleave substrates closer to the non-reducing end 
while PelAh cleaves proximal to the reducing end 
of oligosaccharides. The enzymes also differ in 
their ability to cleave partially deacetylated 
substrates. Although neither enzyme is active 
against fully deacetylated oligosaccharides, PelAh 
has a higher propensity to cleave GalNAc linkages 
within regions of partially deacetylated GAG. The 
structure of PelAh was determined, and comparison 
with Sph3h, revealed a high degree of structural 
similarity within the catalytic site of these enzymes. 
The presence of a deeper, more electronegative 
groove in PelAh likely underlies its ability to bind 
and cleave cationic partially deacetylated substrates 
more effectively than Sph3h. 
RESULTS: 
Sph3h and PelAh are α-1,4-N-
acetylgalactosaminidases 
To elucidate the molecular mechanisms by which 
Sph3h and PelAh mediate biofilm disruption, these 
enzymes were incubated with pre-grown A. 
fumigatus biofilms and the profile of 
oligosaccharides that were released was analyzed 
by Matrix Assisted Laser Desorption and Ionization 
– Time of Flight Mass Spectrometry (MALDI-TOF 
MS) enzymatic fingerprinting. Consistent with our 
previous studies, nanomolar concentrations of 
Sph3h or PelAh disrupted A. fumigatus biofilms 
(Fig. 1A and 1B) (19). Analysis of the 
oligosaccharides released by treatment with either 
enzyme revealed similar MS fingerprints, with 
spectra displaying ions of m/z ratio corresponding 
to N-acetylhexosamine (HexNAc) oligomers. 
Treatment of biofilms with 100 nM Sph3h produced 
ions with a m/z ratio from 1056.5684 to 2478.2696 
with a repetitive occurrence of 203.1002 +/- 0.0059 
matching with the HexNAc m/z ratio (25). This 
profile is consistent with the release of HexNAc 
oligomers ranging in size from pentamers to 
dodecamers (12-mers) (Fig. 1A). Treatment of 
fungal biofilms with 100 nM PelAh generated a 
similar spectrum of ions ranging from m/z 
1056.6345 to 3290.8078, with an interval m/z 
difference of 203.1107 +/- 0.0053 between ions, 
suggesting that PelAh treatment released HexNAc 
oligosaccharides ranging in size from pentamers to 
hexadecamer (16-mers) (Fig. 1B). MS-MS 
fragmentation analysis confirmed these ions were 
composed uniquely of m/z ratio 203.10 units, 
suggesting that these oligosaccharides are HexNAc 
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coupled to mass spectrometry (GC-MS) analysis of 
the monosaccharide composition of these 
oligosaccharides confirmed they are composed 
solely of GalNAc, supporting the hypothesis that 
these enzymes cleave regions of homo-GalNAc 
within GAG (Fig. 1D).   
To further confirm the specificity of Sph3h and 
PelAh for the α-1,4-GalNAc linkages within GAG, 
the ability of these enzymes to cleave synthetic 
oligo-α-1,4-galactose, and oligo-α-1,4-
galactosamine were tested. Neither Sph3h or PelAh 
exhibited activity against these components of 
GAG, even at concentrations as high as 5 µM (Fig. 
2A and B).  Similarly, neither enzyme was able to 
degrade chitin (β-1,4 linked N-acetylglucosamine), 
the only other major hexosamine-containing 
polysaccharide within the fungal cell wall (Fig. 
2C). These data suggest that biofilm disruption by 
Sph3h and PelAh is a consequence of cleavage of α-
1,4-GalNAc homopolymeric regions within GAG. 
Sph3h and PelAh are α-1,4-GalNAc endo-acting 
hydrolases with a minimal substrate length of 7 
GalNAc units. 
To confirm the α-1,4-N-acetylgalactosaminidase 
activity of Sph3h and PelAh, MALDI-TOF MS 
enzymatic fingerprinting was performed using a 
purified fraction of α-1,4-GalNAc oligosaccharides 
obtained by partial Sph3h digestion of A. fumigatus 
biofilms (Fig 2D). Treatment of these 
predominately decameric to dodecameric 
oligosaccharides with either 1 µM Sph3h (Fig 2E) 
or 1 µM PelAh (Fig 2F) for 1 hour resulted in a shift 
of the spectra consistent with final product sizes of 
penta-, hexa- and heptamers, confirming the ability 
of these enzymes to cleave α-1,4-GalNAc linkages. 
To determine the minimum substrate size that can 
be cleaved by Sph3h and PelAh, α-1,4-GalNAc 
hexamers and heptamers purified from partial 
Sph3h digestion of A. fumigatus biofilms were 
treated with each enzyme and the degradation 
products analyzed by MALDI-TOF MS 
fingerprinting. GalNAc heptasaccharides but not 
hexasaccharides were rapidly hydrolyzed by both 
enzymes (Fig. 3A-D). Hydrolysis of GalNAc 
heptasaccharides by Sph3h resulted in the 
accumulation of pentasaccharides (Fig. 3B), while 
PelAh hydrolysis produced predominantly both 
tetra- and pentasaccharides (Fig. 3D) suggesting 
that these enzymes function as endo-acting 
glycoside hydrolases. The ability of PelAh to 
degrade the heptamers into two sets of products 
suggests some flexibility in the positioning of the 
oligosaccharide in the PelAh binding site. 
Sph3h and PelAh are retaining endoglycoside 
hydrolases. 
To investigate the molecular mechanism of the two 
glycoside hydrolases, the stereochemical outcome 
of oligosaccharide cleavage by these enzymes was 
evaluated by 1H-NMR spectroscopy using synthetic 
GalNAc octamers as a substrate. Spectral analysis 
of the pre-reaction substrate demonstrated the 
presence of four doublets with coupling constants 
between 3.5 and 4.0 Hz in the anomeric region of 
the spectra, characteristic of α-glycosidic linkages. 
The addition of Sph3h or PelAh led to the 
appearance of a new peak at 5.29 ppm with a 
coupling constant of 4.0 Hz characteristic of an α-
anomer (Fig 4A and B). Acquisition of 1D spectra 
at 25 °C and 37 °C (Fig 4A and 4B), and of 2D 
COSY 1H-1H spectra (Supplemental Fig. 1) after 24 
h of reaction revealed the appearance of a β-anomer 
signal at 4.73 ppm on the 1D spectra consistent with 
secondary mutarotation at the new reducing end. 
The addition of purified monomeric GalNAc to 
samples at the end of the experiment resulted in the 
appearance of anomeric signals at 4.66 and 5.25 
ppm.  These signals were distinct from the 
experimental products, demonstrating that neither 
Sph3h nor PelAh released monosaccharides from 
GalNAc octamers (supplemental Figure 2). 
Collectively, these data suggest that Sph3h and 
PelAh are retaining endoglycosidases. 
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To shed light on the mechanisms by which PelAh 
and Sph3h hydrolyse α-1,4-GalNAc polymers, and 
to complement the available structure of Sph3h, we 
pursued the structure determination of PelAh. 
Crystals of PelAh formed readily in a variety of 
different crystallization conditions and the structure 
was subsequently determined using 
selenomethionine incorporation and single-
wavelength anomalous diffraction method to 1.54 
Å and refined to a final Rwork and Rfree of 16.9 % and 
19.2 %, respectively. Unambiguous electron 
density allowed the modeling of residues 48 to 300. 
No interpretable density was observed for residues 
47, 301-303, or the hexa-histidine purification tag. 
The structure of PelAh revealed a β8/α7-barrel fold 
with a C-terminal region lacking secondary 
structure (Fig. 5A). This region, residues 290-300, 
packs against the core β-barrel and makes multiple 
contacts to neighboring helices suggesting that the 
lack of helical structure is not an artifact of the 
construct design. Furthermore, secondary structure 
prediction using Jpred4 (26) predicts that residues 
297-310 form a β-strand supporting the lack of an 
eight helix.  
In addition to the core (β/α)-fold, PelAh contains 
two structural insertions.  The first is a 38 amino 
acid loop between β3 and α3 containing a two 
strand anti-parallel β-sheet and two α-helices 
(Loop3 in Fig 5A). The second is a β-hairpin loop 
(βHL) between β6 and α6. These insertions 
contribute to the creation of a 15 Å deep, ~36 Å 
long, active site groove on the “top” face of the 
barrel at the C-termini of the β-strands (Fig. 5A). 
This groove is composed of several aromatics that 
could potentially participate in polysaccharide-
protein interactions (Fig. 5B).  
When the structure of PelAh was submitted to the 
tertiary structure similarity server, DALI (27), the 
most similar structures found were: (i) a 
hypothetical protein TM1410 from Thermatoga 
maritima which has sequence similarity to GH114 
family members (PDB 2AAM, 2.5 Å root-mean-
square deviation RMSD over 203 residues ); (ii) a 
cycloisomaltooligosaccharide glucotransferase 
from GH66 (PDB 3WNK, 2.9 Å RMSD over 165 
residues); (iii) Cwp19, a peptidoglycan hydrolase 
reported as a  GH-like 10 family member (PDB 
5OQ2, 2.9 Å rmsd over 193 residues), and (iv) a 
dextranase from GH66 (PDB 3VMN, 2.9 RMSD 
over 155 residues). TM1410 has the highest 
similarity in structure and highest sequence identity 
to PelAh (15.7%). TM1410 also contains an 
insertion after β3, consisting of a three-stranded β-
sheet and a small α-helix (Loop3TM1410). 
Loop3TM1410 folds further over the putative active 
site than the equivalent Loop3 in PelAh (Fig. 5C). 
Electron density corresponding to a ring containing 
ligand, as well as multiple glycerol molecules, was 
found in the deep groove of the TM1410 structure. 
It is possible that Loop3 TM1410 has some flexibility 
and the presence of a ligand in TM1410 causes the 
loop to cap the groove. Loop3PelA and the βHL have 
the highest B-factors of the PelAh structure, 
reaching 134 Å2 in Loop3 as compared to an 
average protein B-factor of 31.6 Å2, suggesting 
conformational heterogeneity in the crystal, further 
supporting the flexibility of these regions (Fig. 5D). 
PelAh is most closely related to GH114 family as 
previously noted. According to the automated 
carbohydrate active enzymes annotation server 
dbCAN2, PelAh has very low overlap with the 
GH114 HMM profile and has insufficient sequence 
identity to be assigned to this family (28,29). These 
results suggest that PelAh represents a new GH 
family related to GH114. Our experimental 
evidence that PelAh exhibits glycoside hydrolase 
activity allows for the creation of GH166 family. 
Although no GH114 structure has been solved to 
date, the similarity in predicted structure suggests 
that GH166 and GH114 may create a new GH clan 
(30).  
Structural comparison of GAG hydrolyzing PelAh 
and Sph3h reveals architectural differences but 
conserved active site residues.  
A superimposition of PelAh and Sph3h (RMSD of 
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of Sph3h (24) with that of PelAh (19) and revealed 
that the insertions in the PelAh structure are unique 
to this protein (Fig. 6A). Sph3h has a much 
shallower binding cleft compared to PelAh (Fig. 
6B). Active sites situated in clefts and tunnels 
suggest endo-activity and correlates with increased 
processivity (31-33). Shallow substrate grooves 
correlate with low processivity but have been found 
in enzymes that cleave crystalline, recalcitrant 
substrates (31-33). The deeper cleft found in PelAh 
is indicative of a more processive activity as 
compared to Sph3h.  
Despite differences in cleft architecture, 
examination of the putative active sites (RMSD 
0.25 Å over active site motif backbone atoms) 
revealed a high degree of conservation, with 
residues D166, N202 and E222 of Sph3h that 
interact with GalNAc in our co-crystal structure 
(24), superimposing with residues D160, N199 and 
E218 of PelAh (Fig. 5CD). Sph3h activity was 
previously shown to be dependent on D166 as 
conservative mutation of this residue abolished 
Sph3h degradation of GAG (24). Mutation of E222 
to alanine also abolished Sph3h activity but 
replacement with glutamine had a lesser affect. 
Biofilm disruption by PelAh was shown to involve 
E218, which aligns to E222 of Sph3h, suggesting 
this residue is involved in catalysis (19). The 
similarity of the residues within the catalytic site of 
Sph3h and PelAh suggests that they share a common 
catalytic mechanism. The distance between 
carboxyl side chains of the catalytic residues D166 
and E222 in Sph3h and the homologous residues 
D160 and E218 in PelAh are 5.2 – 6.7 Å and 4.8 – 
6.8 Å, respectively. This distance is consistent with 
a retaining (~ 5.5 Å) rather than inverting 
mechanism of cleavage (~ 10 Å) (32).  
Sph3h and PelAh have different distribution of 
substrate binding subsites. 
To determine if Sph3h and PelAh cleave GalNAc 
oligosaccharides closer to the reducing or non-
reducing end, an oligosaccharide preparation 
enriched in (α-1,4-GalNAc)9 was reduced by 
sodium borohydride treatment, conferring an 
additional m/z ratio of 2 to the reducing end. These 
reduced oligosaccharides were then incubated with 
each enzyme and the resulting products analyzed by 
MALDI-TOF MS. Both enzymes produced 
multiple oligosaccharides products ranging in 
length from tetramers to heptamers. However, 
oligosaccharides produced by Sph3h treatment were 
consistent with cleavage of (α-1,4-GalNAc)9 near 
the reducing end of the substrate, while PelAh 
treatment released reduced GalNAc4-6 consistent 
with cleavage near the non-reducing end (Fig 7). 
Mapping of sequence conservation based on 
alignments of Sph3h and PelAh to respective 
homologous proteins revealed high degrees of 
sequence conservation in the active site groove of 
each enzymes (Fig 7C and D). However, closer 
examination of the patterns of conservation shows 
differences between the two enzymes (Fig. 7C and 
D). For Sph3h, surface conservation extends further 
on the non-reducing side of +1/-1 cleavage site 
suggesting approximately five conserved substrate 
binding subsites (-5 to -1, Fig 7C). This observation 
is consistent with our data that shows that this 
enzyme produces a minimum length 
pentasaccharide from the non-reducing end (Fig 
7A). In contrast, PelAh has surface conservation 
that extends on the reducing end side of cleavage 
and at least five subsites could be mapped (+1 to 
+5, Fig 7B). Surface residue conservation thus 
correlates well with the results of the GalNAc9 
hydrolysis experiments. 
PelAh cleaves deacetylated-rich regions within 
GAG 
Comparison of the structures of Sph3h and PelAh 
revealed that the PelAh active site groove is more 
electronegative than that of Sph3h (Fig. 8A), 
suggesting that PelAh may be able to bind and 
potentially cleave cationic oligosaccharides, such 
as partially deacetylated oligo-GalNAc. Although 
neither enzyme was able to cleave α-1,4 GalN 
homopolymers, it is possible that these enzymes 
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within GalN-rich regions of GAG.  Although GalN-
containing oligosaccharides were not detected 
during the biofilm disruption assay (Fig 1), these 
cationic degradation products could have remained 
adherent to the negatively charged hyphal cell wall. 
To test this hypothesis, a cell-free GAG degradation 
assay was performed using purified secreted GAG. 
Sph3h treatment of secreted GAG resulted in the 
release of predominately homo-GalNAc 
oligosaccharides (86%) with a smaller amount of 
mono-deacetylated GalNAc oligosaccharides 
(14%, Fig. 8B). In contrast, treatment of secreted 
GAG with PelAh produced almost exclusively 
partially deacetylated GalNAc oligosaccharides 
(98%, Fig. 8B) suggesting that PelAh preferentially 
binds and degrades GalN-containing regions of 
GAG. Consistent with our prior results, no 
galactose homo- or heteropolymers, nor GalN 
homopolymers were found, confirming that Sph3h 
and PelAh specifically cleave α-1,4 GalNAc 
linkages (Fig. 2B). 
DISCUSSION: 
We previously described the structure of Sph3h and 
found that this enzyme constituted the first member 
of a new glycoside hydrolase family, GH135, with 
activity against GAG and Aspergillus biofilms (24). 
More recently, the glycoside hydrolase domain of 
PelA from P. aeruginosa has also been reported to 
disrupt A. fumigatus biofilms (19). However, the 
molecular mechanism and specificity these 
enzymes had not been elucidated.  
Herein, the mechanism by which these enzymes 
disrupt A. fumigatus biofilms was studied using a 
combination of structural biology, and mass and 
NMR spectroscopy. These studies revealed that 
Sph3h and PelAh share a conserved active site and 
cleave α-1,4-GalNAc glycosidic linkages using a 
retaining enzyme mechanism. Despite these 
similarities of specificity and mechanism, the 
interaction between the enzymes and the substrate 
differ. The Sph3h has a neutral electrostatic cleft in 
contrast to the deep electronegative groove of the 
PelAh. These observations correlate with the nature 
of the products observed after cleavage of secreted 
GAG. The electronegative PelAh was able to bind 
and release cationic GalN-containing 
oligosaccharide more efficiently, while the neutral 
Sph3h released mostly neutral GalNAc 
oligosaccharides. Furthermore, despite interacting 
with the same substrate, the two glycoside 
hydrolases have extended conserved substrate 
binding sites on opposites sides of the catalytic -
1/+1 site. This difference leads to Sph3h cleaving 
closer to the reducing end, while PelAh cleaves 
nearer to the non-reducing end of oligosaccharides.  
Sph3h is structurally similar to GH27 family 
members which rely on two acidic residues to 
cleave the glycosidic bond (24). GH27 catalytic 
residues align structurally with D166 and E222 in 
Sph3h. Previously, mutagenesis studies on Sph3h 
identified D166 as essential for catalysis (24). E222 
was not essential in vitro as mutation to glutamine 
retained some activity (24). Replacement of the 
catalytic acid/base residue with glutamine does not 
abolish activity in some retaining hydrolases but 
slows the rate of reaction (34,35). Mutation of the 
acid/base glutamate in the Sulfolobus solfataricus 
β-glycosidase reduced activity 10- to 60-fold 
depending on the substrate (36). In Sph3h, E222 is 
coordinated by Y88 and N202, and these residues 
may aid in activation of the glutamine in the E222Q 
mutant. PelAh has equivalent catalytic residues that 
align structurally to those of Sph3h. NMR analysis 
found that both enzymes utilize a retaining 
mechanism. Analysis of the structure of Sph3h and 
PelAh revealed that the distances between the 
carboxyl side chains of the catalytic residues E222 
and D166 in Sph3h and E218 and D160 in PelAh 
correspond to the average distance between the 
catalytic residues of retaining hydrolases (32). 
Thus, the structures of Sph3h and PelAh and the 
NMR results are consistent with these enzymes 
utilizing a retaining mechanism (Fig. 4). 
Our findings demonstrate that PelAh and Sph3h 
share a similar (β/α) barrel fold with central grooves 


























galactosaminidase activity. The high identity 
between the catalytic residues of the active site 
suggests that the difference in the ability of these 
enzymes to hydrolyze oligosaccharides containing 
deacetylated residues is a reflection of differences 
in polysaccharide binding affinity. This hypothesis 
is supported by the fact that, unlike Sph3h, the 
binding groove of PelAh is highly electronegative, 
suggesting an affinity for cationic substrates as seen 
in the soluble GAG degradation assay. PelA is a 
multidomain protein with both hydrolase and 
carbohydrate deacetylase activity. The deacetylase 
activity has been shown to be required for in vivo 
Pel dependent biofilm formation (20). Our results 
suggest that the PelA deacetylase domain likely 
acts on Pel first, rendering the polysaccharide 
cationic prior to hydrolysis of the polymer. Similar 
findings have been reported for the poly-β1-6-N-
acetyl-D-glucosamine (PNAG) modifying enzyme, 
PgaB, which contains both a deacetylase domain 
and a GH153 hydrolase domain (37). Studies of 
PgaB demonstrated that the GH153 domain 
requires a specific pattern of partially deacetylated 
PNAG as a substrate (37). PelAh appears to be more 
promiscuous in its substrate specificity, as the 
enzyme can hydrolyze pure acetylated oligomers. 
Another difference between Sph3h and PelAh was 
revealed by their activity on reduced GalNAc 
nonamers (Fig 7). Sph3h hydrolyzed 
oligosaccharides proximal to the reducing end 
while PelAh cleaved near the non-reducing end. 
This observation suggests differences in the roles of 
the substrate binding residues on either side of the 
catalytic site in each enzyme. This hypothesis is 
substantiated by the differences in surface residue 
conservation in the putative binding grooves of 
Sph3h and PelAh. Sph3h contains a longer stretch of 
conserved residues on the non-reducing side of the 
-1/+1 cleavage site. The conserved residues in 
Sph3h span the -5 to +2 binding subsites. In 
contrast, the conserved surface of PelAh aligns with 
-2 to +5 subsites. 
Previously, we reported that PelAh was able to 
disrupt both GAG- and Pel-dependent biofilms. In 
contrast, Sph3h was only active only against GAG-
dependent fungal biofilms, and was unable to 
cleave Pel-dependent biofilms despite being able to 
bind Pel polysaccharide(19,24). The results of our 
structure function studies reveal important 
differences in the substrate specificity and structure 
of these enzymes that may explain these 
observations. PelAh was found to have a deeper, 
more electronegative substrate binding groove and 
exhibit preferential activity against partially 
deacetylated substrates compared with Sph3h. 
While Sph3h treatment of soluble GAG releases 
predominately acetylated oligomers, treatment with 
PelAh releases 98% partially deacetylated products. 
Although the detailed structure of Pel has not been 
determined, compositional studies suggest it 
contains both GlcNAc and GalNAc (23). The 
degree of deacetylation, and the identity of the 
sugars deacetylated in the Pel polysaccharide have 
not been determined. Our results suggest the 
inactivity of Sph3h against Pel may reflect the fact 
that Pel is more extensively deacetylated than 
GAG. Alternately, while the activity of PelA 
against α-linked N-acetyl galactosamine suggests 
that these α-linkages are present within Pel, it is 
possible that the presence of GlcNAc sugars within 
the Pel polymer may interfere with Sph3h ability to 
cleave the Pel polymer. Distinguishing among these 
possibilities, and confirming the presence of α-
linked N-acetyl galactosamine in Pel will require a 
complete structural analysis of this 
polysaccharide.The results of these studies assign 
enzymatic function to two new glycoside 
hydrolases. Sph3h is the only GH135 family 
member that has been functionally characterized. 
While the structure of Sph3h had been previously 
determined (24), the current study expands our 
understanding of the activity of this enzyme and 
demonstrates that Sph3h functions as a retaining 
endo-α-1,4-N-acetylgalactosaminidase with 
specificity for fungal GAG. We also found that the 
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acetylgalactosaminidase. As the sequence identity 
between PelAh and current glycoside hydrolase 
families is low, our structural and functional 
characterization of this protein has enables us to 
classify PelAh as the first member of a new family, 
GH166.  
 
MATERIAL AND METHODS: 
Protein expression and purification of PelAh for 
structural studies - PelAh encompassing residues 
47-303 of the mature PelAh protein was expressed 
and purified as previously described (21). 
Selenomethionine (Se-Met) labeled protein was 
produced as previously described (38) with B834 
Met- E. coli cells (Novagen) and purified as 
described for the native protein. 
Biofilm disruption assay - 104 A. fumigatus conidia 
were grown in Brian media in polystyrene, 96-well 
plates non-tissue culture treated for 21 h at 37 °C 
and then treated with the indicated concentration of 
glycoside hydrolase in 1X PBS for 1 h at room 
temperature under gentle agitation. Biofilms were 
then washed, stained with 0.1% (w/v) crystal violet 
and destained with 100% ethanol for 10 min. The 
optical density of the destain solution was measured 
at 600 nm. 
MALDI-TOF MS enzymatic fingerprint - Products 
of enzymatic digestions were diluted in 0.2% 
Trifluoroacetic acid (TFA) before being spotted on 
the MALDI-TOF plate in a ratio 1:1 (v:v) with 5 
mg/ml dihydroxybenzoic acid (DHB) matrix 
reconstituted in acetonitrile ACN - 0.2% TFA 
(70:30, v:v). Spectra were recorded on a Bruker 
UltrafleXtreme in positive reflector mode and 
represent an accumulation of 5000 laser shots. 
MALDI-TOF MS/MS experiments were performed 
using the same mass spectrometer. 
Gas chromatography-Mass spectrometry 
monosaccharide composition - Oligosaccharides 
enzymatically extracted from biofilm were 
hydrolysed with 6M hydrochloric acid (HCl) for 4 
h at 100 °C. After drying, samples were derivatized 
and analyzed as previously described (39). Briefly, 
samples were then converted in methyl glycosides 
by heating in 1 M methanol-HCl (Supelco) for 16 h 
at 80°C. Samples were dried, washed twice with 
methanol prior re-N-acetylating hexosamine 
residues. Re-N-acetylation was performed by 
incubation with a mix of methanol : pyridine : 
anhydride acetic (10 : 2 : 3) for 1h at room 
temperature. Samples were then treated with 
hexamethyldisilazane : trimethylchlorosilane : 
pyridine solution (3: 1: 9, Supelco) for 20 min at 80 
°C. The resulting trimethylsilyl methyl glycosides 
were dried, resuspended in 1 mL of cyclohexane 
and injected in the Trace1300 GC-MS system 
equipped with a CP-Sil5-CB capillary column 
(Agilent Technologies). Elution was performed 
with the following temperature gradient: 120 °C to 
160 °C at a rate of 10 °C/min, 160 °C to 220 °C at 
a rate of 1.5 °C/min, 220 °C to 280 °C at a rate of 
20 °C/min. Identification and quantification of each 
monosaccharides were carried out using standards 
and response factors determined for each 
monosaccharide. 
Production of oligosaccharide of chitin, α-1,4-Gal 
and α-1,4-GalN and specificity study - 
Oligosaccharides of Chitin/chitosan were produced 
by acidic partial hydrolysis of chitin from shrimp 
shell (Sigma). Briefly, chitin was incubated in 0.1 
M HCl for 2 h at 100 °C. Solubilized 
oligosaccharides were then purified on a Hypersep 
Hypercarb SPE cartridge (Thermofisher) 
conditioned as per manufacturer instructions. After 
loading the sample, the cartridge was washed with 
water, 5% (v/v) ACN, and oligosaccharides were 
eluted with 50% (v/v) ACN. 
The α-1,4-Gal and α-1,4-GalN oligosaccharides 
were chemically synthetized based on the use of di-
tert-butylsilylene (DTBS) group-protected building 
blocks. These extremely powerful cis-
galactosylating agents only produced α-isomer 
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group was removed with HF.pyridine. The resulting 
free 6-hydroxyl group was protected with benzoyl 
group selectively to afford the acceptor. The final 
compounds were obtained after deprotection by 
saponification, debenzylation, azide reduction and 
acetylation of amine groups. 
All oligosaccharides were incubated with 5 µM 
Sph3h or PelAh for 1 h at room temperature and 
analyzed by MALDI-TOF MS. Controls of enzyme 
functionality were performed using as substrate α-
1,4-GalNAc oligosaccharides produced as 
described below. 
Enzymatic mechanism determination by 1H-NMR 
– Proton NMR spectra were recorded on an 
AVANCE III HD 600 NMR spectrometer 
(Ascend™ 600 magnet - Bruker Biospin Ltd.) 
operating at a frequency of 600.17 MHz for 1H and 
equipped with a quadruple resonance CryoProbe 
(CPQCI 1H-31P/13C/15N) and a 
SampleJETTM autosampler. For each sample, 
0.45 mg of α-1,4-GalNAc octamer was 
resuspended in 160 µL 0.1X PBS in D2O 
containing 0.5 mM trimethylsilylpropanoic acid 
(TSP) and transferred in a 3 mm NMR tube. The 1H 
NMR spectra were continuously acquired at 25 °C 
for 4 h with lock and shim performed on every 10 
experiments. A new spectrum at 25°C was recorded 
after 24h to observe the mutarotation and 
confirmation of this event was validated with the 
acquisition of 1H NMR spectra at 37 °C and a 2D 
1H-1H Correlation Spectroscopy (COSY) spectra at 
25 °C. The 1H spectra were acquired using the pulse 
sequence noesypr1d (Bruker Biospin Ltd) in order 
to achieve good suppression of the water signal. 
Each 1H spectrum was acquired with 32 scans, a 1H 
90º pulse length of 7.8 μs, a mixing time of 10 ms, 
a spectral width of 12 kHz, a recycle delay of 4 s for 
a total of 66K data points. The 2D 1H-1H COSY 
spectra were acquired using 16 scans with a 1H 90º 
pulse length of 8 μs, a spectral width of 3 kHz in 
both dimensions, a repetition delay of 1.8 s for a 
total of 2048 data points in F2 and 128 increments 
in F1. All spectra were processed using TOPSPIN 
software (version 3.5 pl 7, Bruker Biospin Ltd). 
Production of pure α-1,4-GalNAc oligosaccharides 
– A. fumigatus biofilm were incubated with 5 nM 
Sph3h for 1 h at room temperature, solubilized 
oligosaccharides were then further purified on a 
Sep-pak C18 cartridge. In brief, cartridges were 
conditioned using absolute ethanol followed by 
water. Samples were then loaded onto the cartridge 
before washing and eluting using a 0.25% (v/v) step 
gradient of methanol from 0 to 4% (v/v) followed 
by a 1% (v/v) step gradient of ACN from 1 to 4%.  
Reduction of oligosaccharides - Reduction of the α-
1,4-GalNAc 9-mer was performed resuspending the 
oligosaccharides in 1 M ammonium hydroxide 
containing 10 mg/ml sodium borohydride and 
incubating overnight at room temperature. Reaction 
was quenched adding dropwise 30% (v/v) acetic 
acid and samples were purified using a Hypersep 
Hypercarb SPE cartridge (Thermofisher) as per 
chitin oligosaccharide purification. 
Crystallization, data collection, and structure 
solution - Purified PelAh was concentrated to ~20 
mg/mL and crystallization trials were performed 
using MCSG1-4 sparse-matrix screens (Microlytic) 
in 48-well hanging-drop VDX plates (Hampton 
Research) using a 2 μL drop with a 1:1 
protein:precipitant ratio at 20 °C. Initial 
crystallization hits were obtained in several 
conditions. Diffraction quality native PelAh crystals 
were grown using 0.1 M Bis-Tris pH 7.5, 25% 
(w/v) PEG MME 5000 at a 1:2 ratio of protein to 
crystallization solution at 20 °C. Se-Met-labeled 
PelAh was crystallized in a similar condition with 
26% (w/v) PEG MME 5000. Both crystals were 
cryoprotected for 10 s in mother liquor 
supplemented with 15% (v/v) ethylene glycol prior 
to vitrification in liquid nitrogen. 
Diffraction data were collected at -173°C with 
wavelengths of 0.9791 and 1.075 Å on beamline 
X29, National Synchrotron Light Source (NSLS) 
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respectively. A high redundancy dataset was 
generated for the Se-Met labeled PelAh by 
collecting 90 images with 2° oscillation at 90% 
beam attenuation and with an exposure time of 0.3 
s/image and 360 images with 1° oscillation with 
50% beam attenuation with an exposure time of 0.4 
s/image on an ADSC Quantum-315 detector with a 
260 mm crystal-to-detector distance. The native 
PelAh dataset was collected using the same strategy 
as described above for the Se-Met crystal but with 
a 180 mm crystal-to-detector distance. Autosol (40) 
was used to determine initial phases and generate a 
density-modified map. The resulting electron 
density map was of high quality and enabled 
PHENIX AutoBuild to build >95 % of the protein. 
The remaining residues were built manually in 
COOT (41,42) and the structure refined using 
PHENIX.REFINE (43). 
Translation/Libration/Screw (TLS) groups were 
added to the refinement in PHENIX through the use 
of the TLSMD server (44,45).  
All structure figures were generated using the 
PyMOL molecular graphics system (DeLano 
Scientific) (46), or Chimera (47) for electrostatics 
using APBS (48). Structural similarity to deposited 
structures in the protein data bank (PDB) was 
determined using DALI and structure alignment 
was performed in COOT (27,41). Amino acid 
conservation was calculated using the Consurf 
server (49) aligned to 113 proteins using the default 
settings. Programs used for crystallographic data 
processing and analysis were accessed through 
SBGrid (50). 
Secreted GAG purification and digest - Secreted 
purified GAG was prepared as previously reported 
(13). Briefly, culture supernatant of a 3 days old 
Af293 culture was filtered on Miracloth prior to be 
ethanol precipitated. Precipitate was then 
successively washed with 70% (v/v) ethanol twice, 
150 mM NaCl and water. The remaining gel was 
then freeze dried. The dried purified GAG was 
incubated with the 1 µM glycoside hydrolase for 1 
h in 0.1X PBS. The released soluble 
oligosaccharides were then analyzed using the 
MALDI-TOF MS enzymatic fingerprint technique.  
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GAG: Galactosaminogalactan 
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RMSD: Root Mean Square Deviation 
PNAG: Poly-β-1,6-N-acetyl-D-glucosamine 
DHB : DiHydrohybenzoic acid 
ACN : Acetonitrile 
HCl : Hydrolchloric acid 
DTBS : Ditert-butylsilylene 
TSP : Trimethylsilylopropanoic acid 
SPE : Solid Phase Extraction 
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TABLE 1: Summary of data collection and refinement statistics. 
(Values in parentheses correspond to the highest resolution shell). 
 SeMet PelAh PelAh 
Data collection   
Beamline NSLS X29 NSLS X29 
Wavelength (Å) 0.979 1.075 
Space group P21212 P21212 
Cell dimensions     
    a, b, c (Å) 61.3, 85.2, 47.2 65.0, 84.0, 47.2 
        ()  90, 90, 90 90, 90, 90 
Resolution (Å) 50.0 – 1.90 (1.97-1.90) 50.00 – 1.54 (1.58-1.54) 
No. reflections 304767 665419 
No. of unique reflections 19863 39193 
I / I 21.7 (4.5) 18.6 (6.6) 
Completeness (%) 99.8 (99.7) 99.9 (99.5) 
Rmerge (%) 12.2 (62.5) 18.1 (44.3) 
   
Refinement   
Rwork / Rfree  16.9 / 19.2 
No. of atoms   
Protein  1935 
Water  193 
Average B-factors (Å2)   
Protein  31.6 
Water  38.3 
RMS deviations   
Bond lengths (Å)  0.008 
Bond angles ()  0.94 
Ramachandran plot   
Total favored (%)  96.8 
Total allowed (%)  100 
Coordinate error (Å)   0.13 
PDB code  5TCB 
1Rmerge= ∑∑ | I (k) - <I>| / ∑ I (k) where I (k) and <I> represent the diffraction intensity values of the 
individual measurements and the corresponding mean values. The summation is over all unique 
measurements. 
2Rwork= ∑ ||Fobs| - k|Fcalc|| / |Fobs| where Fobs and Fcalc are the observed and calculated structure factors, 
respectively. 
2Rfree is the sum extended over a subset of reflections (5%) excluded from all stages of the refinement.  
3As calculated using MolProbity (51). 
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Figure 1. A. fumigatus biofilm degradation by Sph3h and PelAh release α-1,4-GalNAc 
oligosaccharides. (A)  Crystal violet staining of pre-grown A. fumigatus biofilm treated with the indicated 
concentration of Sph3h and the associated MALDI-TOF MS spectra of oligosaccharides released from the 
biofilm treated with 100nM Sph3h (circled concentration) (B) Crystal violet staining of pre-grown A. 
fumigatus biofilms treated with the indicated concentration of PelA
h
 and the associated MALDI-TOF MS 
spectra of oligosaccharides released from the biofilm treated with 100nM PelA
h
 (circled concentration). (C) 
MS-MS fragmentation spectra of m/z=1665.7 ion issued of the Sph3h treatment and matching with HexNAc8 
oligosacaccharide. This structure is a homopolymer of units with an average m/z of 203.1086, corresponding 
to the m/z ratio of a N-acetylhexosamine (white square), consistent with a HexNAc
8
 oligosaccharide. (D) 
GC-MS extracted ion chromatogram m/z=173.0 of HexNAc monosaccharide standards mix. (E) GC-MS 
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Figure 2. Sph3h and PelAh are specific for α-1,4-GalNAc. MALDI-TOF MS analysis of the products 
released by the incubation of Sph3h and PelAh with (A) a fraction enriched in α-1,4-galactose 9-mers, and 
(B) a fraction enriched in α-1,4-galactosamine 9-mers, (C) chemically partially hydrolysed chitin. Initial 
sample is represented in white, following Sph3h treatment in grey and PelAh treatment in black. MALDI-
TOF MS spectra of (D) a sample enriched in α-1,4-GalNAc 4-mer to 15-mer. MALDI-TOF MS spectra of 































































































































































































































































































































































































































































































































































































































































































Figure 3. Sph3h and PelAh are endo-N-acetylgalactosaminidases with a minimum substrate size of 
seven residues. Degradation time course of pure oligosaccharides monitored over 30 minutes by MALDI-
TOF MS. Sph3h degradation kinetic of (A) α-1,4-GalNAc 6-mers and (B) α-1,4-GalNAc 7-mers. PelAh 
degradation kinetic of (C) α-1,4-GalNAc 6-mers and (D) α-1,4-GalNAc 7-mers. Relative proportion of each 
ions was calculated and reported here under the color purple for 7-mer; green for 6-mer, blue for 5-mer, red 
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Figure 4. Sph3h and PelAh are acting as retaining glycoside hydrolases. Degradation time course of α-
1,4-GalNAc octamers by (A) Sph3h and (B) PelAh monitored by NMR spectroscopy highlighting the region 
between 4.6 to 5.4 ppm. All spectra were recorded at 25°C except the final point at 48h, which was also 
acquired at 37 °C as indicated by the *.  
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Figure 5. The structure of PelAh reveals a (β/α)-barrel. (A) Tertiary structure of PelAh with the (β/α) fold 
coloured in orange and yellow, respectively. The β-hairpin (βHL) and the insertion after β3 (Loop3) are 
coloured in blue. (B) The active site groove is shown with a transparent surface allowing for visualization 
of the conserved residues residing in the cleft based on Consurf analysis. In orange are the three residues 
identified as highly conserved in Sph3 homologues. (C) Cα alignment of PelAh (yellow and blue) to 
hypothetical protein TM1410 (PDB 2AAM, grey and black) shows similarity in tertiary structure topology. 
The insertions of PelAh are coloured as in panel (A) showing that TM1410 also contains these additions 
including a loop after β3 (Loop3TM1410, black). An unknown ligand (red) and glycerol (grey) were found in 
the groove of the TM1410 structure. (D) Visualization of PelAh structure B-factors, coloured blue to red for 














































 Figure 6. PelAh and Sph3h differ in their substrate binding cleft architecture but share catalytic 
motifs. (A) Tertiary structure alignment of Sph3h (PDB 5D5G, purple) with PelAh. (B) Transparent surface 
representation of PelAh (yellow and blue) and Sph3h (purple) in the same orientation shows the relative 
depths of the active site groove. (C) Alignment of the active site residues of PelAh (yellow) and Sph3h 
(purple) based on the Sph3h active site motifs shows high identity between the hydrolases around the 
GalNAc (grey) binding site of Sph3h (PDB 5D6T). (D) Primary sequence alignment of P. aeruginosa PelAh 
(PelAPa) with homologues from Geobacter metallireducens (PelAGm), Ralstonia solanacearum (PelARs) as 
well as TM1410 and Sph3 (Aspergillus clavatus) done by MUSCLE. Sequence identity to PelAh is listed 



























PelAPa 100 % GLFLDTLDSF
PelAGm 37 % GFFLDTLDSY
PelARs 34 % GFFLDTLDSY
TM1410 16 % GIYLDRIDSF
Sph3 15 % GIFFDEITPQ
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Figure 7. Sph3h and PelAh do not hydrolyze the oligosaccharide at the same location. (A) MALDI-TOF 
MS spectra of the enzymatic product of Sph3h and (B) PelAh cleavage of reduced α-1,4-GalNAc 9-mers. 
and their associated schematic view of the cleavage sites. Yellow squares represent GalNAc, arrows indicate 
enzymatic cleavage sites, * indicates the reducing end of the oligosaccharides. † indicates matrix ion signals. 
(C) Surface representation coloured by conservations (conserved in magenta and variable in teal, catalytic 
residues in black) showing a proposed map of a heptamer substrate and product subsites on Sph3h and (D) 














































































































































































































 Figure 8. Difference in electrostatic charge surface predict PelAh is preferentially able to cleave 
oligosaccharides containing deacetylated GalNAc. (A) Electrostatic surface representation of Sph3h and 
PelAh generated using APBS in Chimera. Quantitative electrostatics are colored from red (-15kT) to blue 
(+15kT). (B) Relative proportions of oligosaccharides obtained from digestion of purified, secreted GAG 
degradation products with 1µM of Sph3h or PelAh. Oligosaccharide products were detected by MALDI-
TOF MS. Ions were categorized according to their composition as indicated in the legend. No galactose-
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